Table 1.
Model Inputs and Sources Used to Calculate Employer-Paid Nonmedical Costs of Employees with Diabetes and End-Stage Renal Disease (ESRD), by Type of Cost
| Model Inputa | Data Source |
| Life insurance costs | |
| % ESRD-related deaths | |
| % with diabetes and ESRD | USRDS (11) |
| % ESRD-related deaths | USRDS (11) and Milliman Basic Mortality Tables (12) |
| Life-insurance benefit amounts | |
| Typical benefit as % of salary* | Published references (13-15) |
| Employee salary | U.S. Department of Labor (16,17) |
| Disability insurance costs | |
| % ESRD-related disability claims | |
| % with diabetes and ESRD | USRDS (11) |
| % with ESRD-related disability* | Assumption based on medical director interviews |
| Disability benefit amounts | |
| Typical benefit as % of salary* | Published references (18,19) |
| Length of disability claim (i.e., continuance) | Milliman, Inc proprietary disability database |
| Discount rate | Assumption based on expected returns on typical investments by disability insurers |
| Employee salary | U.S. Department of Labor (16,17) |
| Costs of replacing a worker | |
| % workers lost due to ESRD | |
| % with diabetes and ESRD | USRDS (11) |
| % with ESRD-related disability | Assumption based on medical director interviews |
| Employee turnover amount | |
| Turnover costs as % of salary* | Published references (20,21) |
| Employee salary | U.S. Department of Labor (16,17) |
USRDS indicates United States Renal Data System
All model inputs except those marked with an asterisk (*) were age and sex specific.